Medicare Drug Price Talks Become A Long-Term Industry Reality

Medicare drug negotiations are no longer a one-off fight - they are becoming a lasting reality for the pharmaceutical industry. That means companies, regulators, and patients are now operating in a system where Washington has a bigger hand in pricing than before. Supporters will call it reform, but critics see another example of federal power expanding deeper into the health-care marketplace. Read more about this...